The regulation of energy generating metabolic pathways by p53
暂无分享,去创建一个
[1] Eyal Gottlieb,et al. TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.
[2] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[3] M. Oren,et al. Decision making by p53: life, death and cancer , 2003, Cell Death and Differentiation.
[4] S. Willis,et al. Life in the balance: how BH3-only proteins induce apoptosis. , 2005, Current opinion in cell biology.
[5] Saroj P. Mathupala,et al. Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria , 2006, Oncogene.
[6] Z. Herceg,et al. Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. , 2001, Mutation research.
[7] Oksana Gavrilova,et al. p53 Regulates Mitochondrial Respiration , 2006, Science.
[8] Saroj P. Mathupala,et al. Aberrant Glycolytic Metabolism of Cancer Cells: A Remarkable Coordination of Genetic, Transcriptional, Post-translational, and Mutational Events That Lead to a Critical Role for Type II Hexokinase , 1997, Journal of bioenergetics and biomembranes.
[9] T. A. Smith,et al. Mammalian hexokinases and their abnormal expression in cancer. , 2000, British journal of biomedical science.
[10] K. Takata,et al. Hexokinase-II expression in untreated oral squamous cell carcinoma: Comparison with FDG PET imaging , 2005, Annals of nuclear medicine.
[11] Joseph R. Milner,et al. An ATP/ADP-Dependent Molecular Switch Regulates the Stability of p53-DNA Complexes , 1999, Molecular and Cellular Biology.
[12] S. Deb,et al. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53 , 1996, Molecular and cellular biology.
[13] H. Pelicano,et al. Glycolysis inhibition for anticancer treatment , 2006, Oncogene.
[14] T. Bourgeron,et al. Fluxes of Nicotinamide Adenine Dinucleotides through Mitochondrial Membranes in Human Cultured Cells* , 1996, The Journal of Biological Chemistry.
[15] S. Weinhouse. On respiratory impairment in cancer cells. , 1956, Science.
[16] David Beach,et al. Glycolytic enzymes can modulate cellular life span. , 2005, Cancer research.
[17] Zhuchu Chen,et al. Proteome analysis of human lung squamous carcinoma , 2006, Proteomics.
[18] Sam W. Lee,et al. p53 induction of heparin‐binding EGF‐like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades , 2001, The EMBO journal.
[19] Kai Chen,et al. Activation of p53 by Oxidative Stress Involves Platelet-derived Growth Factor-β Receptor-mediated Ataxia Telangiectasia Mutated (ATM) Kinase Activation* , 2003, Journal of Biological Chemistry.
[20] P. Chumakov,et al. The antioxidant function of the p53 tumor suppressor , 2005, Nature Medicine.
[21] T. Finkel,et al. A role for mitochondria as potential regulators of cellular life span. , 2002, Biochemical and biophysical research communications.
[22] L. Guarente,et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. , 2001, Cell.
[23] Yusuke Nakamura,et al. p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.
[24] P. Bradshaw,et al. Loss of NAD(H) from swollen yeast mitochondria , 2006, BMC Biochemistry.
[25] J. Herrera,et al. A potential role for fructose-2,6-bisphosphate in the stimulation of hepatic glucokinase gene expression. , 2004, Endocrinology.
[26] R. Weinberg,et al. hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase , 2001, Cell.
[27] C. Prives,et al. The p53 pathway , 1999, The Journal of pathology.
[28] M. Takagi,et al. NAD+ Modulates p53 DNA Binding Specificity and Function , 2004, Molecular and Cellular Biology.
[29] Delin Chen,et al. Negative Control of p53 by Sir2α Promotes Cell Survival under Stress , 2001, Cell.
[30] K. Chien,et al. p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[31] V. Ferrans,et al. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] A. N. Wick,et al. 2-Deoxyglucose—A Metabolic Block for Glucose.∗ , 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[33] Yusuke Nakamura,et al. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses , 2004, Journal of Human Genetics.
[34] N. Holbrook,et al. Cellular response to oxidative stress: Signaling for suicide and survival * , 2002, Journal of cellular physiology.
[35] W. Deppert,et al. Transcription-independent pro-apoptotic functions of p53. , 2005, Current opinion in cell biology.
[36] K. Kinzler,et al. A model for p53-induced apoptosis , 1997, Nature.